Deferred Tax Assets, Gross of HAEMONETICS CORP from 02 Apr 2011 to 29 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: HAEMONETICS CORP quarterly Deferred Tax Assets, Gross in USD history and change rate from 02 Apr 2011 to 29 Mar 2025.
HAEMONETICS CORP Deferred Tax Assets, Gross for the quarter ending 29 Mar 2025 was $97,117,000, a 7.7% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Gross, Quarterly (USD)

Deferred Tax Assets, Gross, YoY Quarterly Change (%)

HAEMONETICS CORP Quarterly Deferred Tax Assets, Gross (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$97,117,000	-$8,148,000	-7.7%	29 Mar 2025	10-K	21 May 2025	2025	FY
Q1 2024	$105,265,000	+$14,904,000	+16%	30 Mar 2024	10-K	21 May 2025	2025	FY
Q1 2023	$90,361,000	+$5,038,000	+5.9%	01 Apr 2023	10-K	20 May 2024	2024	FY
Q1 2022	$85,323,000	-$8,844,000	-9.4%	02 Apr 2022	10-K	22 May 2023	2023	FY
Q1 2021	$94,167,000	+$39,159,000	+71%	03 Apr 2021	10-K	25 May 2022	2022	FY
Q1 2020	$55,008,000	+$19,462,000	+55%	28 Mar 2020	10-K	26 May 2021	2021	FY
Q1 2019	$35,546,000	-$4,466,000	-11%	30 Mar 2019	10-K	20 May 2020	2020	FY
Q1 2018	$40,012,000	-$19,006,000	-32%	31 Mar 2018	10-K	22 May 2019	2019	FY
Q1 2017	$59,018,000	-$7,024,000	-11%	01 Apr 2017	10-K	23 May 2018	2018	FY
Q1 2016	$66,042,000	+$16,181,000	+32%	02 Apr 2016	10-K	24 May 2017	2017	FY
Q1 2015	$49,861,000	+$61,153,000		28 Mar 2015	10-K	01 Jun 2016	2016	FY
Q1 2014	$11,292,000	+$1,786,000	+14%	29 Mar 2014	10-K	22 May 2015	2015	FY
Q1 2013	$13,078,000	-$939,000	-7.7%	30 Mar 2013	10-K	22 May 2014	2013	FY
Q1 2012	$12,139,000	-$7,958,000	-190%	31 Mar 2012	10-K	20 May 2013	2012	FY
Q1 2011	$4,181,000			02 Apr 2011	10-K	22 May 2012	2011	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.